Persistence on treatment and blood pressure control with different first-line antihypertensive treatments: A prospective evaluation

Clinical and Experimental Hypertension

Volumn 29, Issue 8, 2007, Pages 553-562

  Prandin, Maria Grazia ^a   Cicero, Arrigo F G ^a   Veronesi, Maddalena ^a   Cosentino, Eugenio ^a   Dormi, Ada ^a   Strocchi, Enrico ^a   Borghi, Claudio ^a,b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Antihypertensive drugs; Blood pressure; Hypertension; Persistence

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; LERCANIDIPINE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; DISEASE DURATION; FEMALE; HEART RATE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OUTCOME ASSESSMENT; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT PLANNING;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; FEMALE; HUMANS; HYPERTENSION; MALE; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 36849006402     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.1080/10641960701744061     Document Type: Article

References (23)

1. JNC VII. The Seven Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-1252.
2. Staessen JA, Li Y, Thijs L, Wang JG. Blood pressure reduction and cardiovascular prevention: An update including the 2003-2004 secondary prevention trials. Hypert Res. 2005;28(5):385-407.
3. Psaty BM, Smith NL, Siscovick DS, Koepsell TD, Weiss NS, Heckbert SR, Lemaitre RN, Wagner EH, Furberg CD. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. J Am Med Assoc. 1997;277:739-745.
4. Wolf-Maier K, Cooper RS, Kramer H, Banegas JR, Giampaoli S, Joffres MR, Poulter N, Primatesta P, Stegmayr B, Thamm M. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 2004;43(1):10-17.
5. Erdine S, Ari O, Zanchetti A, Cifkova R, Fagard R, Kjeldsen S, Mancia G, Poulter N, Rahn KH, Rodicio JL, Ruilope LM, Staessen J, van Zwieten P, Waeber B, Williams B. ESH-ESC guidelines for the management of hypertension. Herz. 2006;31(4):331-338.
6. McCombs IS, Nichol MB, Newman CM, Sclar DA. The costs or interrupting antihypertensive drug therapy in a Medicaid population. Med Care. 1994;32:214-226.
7. Fujita T, Shimamoto K, Wu Z, Zhu J, Chung NS, Park JB, Lee YT, Liau CS, Chen MF. What are the major challenges in getting patients to the optimal BP goal? Difficulties in educating doctors and patients. Int J Clin Pract Suppl. 2006;150:20-22.
8. David DS. Compliance with hypertensive therapy. Hypertension 2006;48(4):E16.
9. Ambrosioni E, Leonetti G, Pessina AC, Rappelli A, Trimarco B, Zanchetti A. Patterns of hypertension management in Italy: Results of a pharmacoepidemiological survey on antihypertensive therapy. Scientific Committee of the Italian Pharmacoepidemiological Survey on Antihypertensive Therapy. J Hypert. 2000;18(11):1691-1699.
10. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265:3255-3264.
11. Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Levin R, Avorn J. The effects or initial drug choice and comorbidity on antihypertensive therapy compliance: Results from a population based study in the elderly. Am J Hypert. 1997;10:697-704.
12. Okano GJ, Rascati KL, Wilson JP, Remund DD, Grabenstein JD, Brixner DI. Patterns or antihypertensive use among patients in the US Department of Defense database initially prescribed an angiotensin-converting enzyme inhibitor or calcium channel blocker. Clin Ther. 1997;19:1433-1444.
13. Jones JK, Gorkin L, Lian JF, Staffa JA, Fletcher AP. Discontinuation or and changes in treatment after start or new courses or antihypertensive drugs: A study or a United Kingdom population. Brit Med J. 1995;311:293-295.
14. Blooms BS. Continuation of initial antihypertensive medication after one year of therapy. Clin Ther. 1998;20(4):671-681.
15. Perreault S, Lamarre D, Blais L, Dragomir A, Berbiche D, Lalonde L, Laurier C, St-Maurice F, Collin J. Persistence with treatment in newly treated middle-aged patients with essential hypertension. Ann Pharmacother. 2005;39(9):1401-1408.
16. Poluzzi E, Strahinja P, Vargiu A, Chiabrando G, Silvani MC, Motola D, Sangiorgi Cellini G, Vaccheri A, De Ponti F, Montanaro N. Initial treatment of hypertension and adherence to therapy in general practice in Italy. Eur J Clin Pharmacol. 2005;61(8):603-609.
17. Messerli FH. Calcium antagonists in hypertension: from hemodynamics to outcomes. Am J Hypert. 2002;15(7 Pt 2):94S-97S.
18. ESH-ESC. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. Guidelines Committee. J Hypert. 2003;21:1011-1053.
19. Black DM, Brand RJ, Greenlick M, Hughes G, Smith J. Compliance to treatment for hypertension in elderly patients: The SHEP pilot study. J Gerontol. 1987;42:552-557.
20. Grimm RH Jr, Grandits GA, Cutler JA, Stewart AL, McDonald RH, Svendsen K, Prineas RJ, Liebson PR. Relationships of quality-of-life measures to long-term lifestyle and drug treatment in the Treatment of Mild Hypertension Study. Arch Intern Med. 1997;157(6):638-648.
21. Borghi C. Lercanidipine in hypertension. Vasc Health Risk Manag. 2005;1:173-182.
22. Bang LM, Chapman TM, Goa KL. Lercanidipine: A review of its efficacy in the management of hypertension. Drugs 2003;63(22): 2449-2472.
23. Borghi C, Dormi A, D'Addato S, Gaddi A, Ambrosioni E; Brisighella Heart Study Working Party. Trends in blood pressure control and antihypertensive treatment in clinical practice: The Brisighella Heart Study. J Hypert. 2004;22(9):1707-1716.